Endophthalmitis after injections of anti-vascular endothelial growth factor drugs.

摘要

The April 2011 edition of Retina featured 3 important articles regarding endophthalmitis after anti-vascular endothelial growth factor drug injections: a meta-analysis of the existing literature byMcCannel, large Bascom Palmer Eye Institute series by Moshfe-ghi et al, and the editorial by Wykoff and Flynn. Two important conclusions emerge from these reports. First, the overall incidence of endophthalmitis is low and is not altered by the prophylactic use of topical antibiotics. Second, the frequency of streptococcal endophthalmitis is higher after intravitreal injections than after other ophthalmic surgical procedures. Given the high likelihood of permanent vision loss associated with streptococcal endophthalmitis, this second point deserves further discussion.